P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPDATED RESULTS FROM LOTIS-2, THE PIVOTAL PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

• Paolo F Caimi,
• Weiyun Z Ai,
• Juan Pablo Alderuccio,
• Kirit M Ardeshna,
• Mehdi Hamadani,
• Brian Hess,
• Brad S Kahl,
• John Radford,
• Melhem Solh,
• Anastasios Stathis,
• Pier Luigi Zinzani,
• Ying Wang,
• Yajuan Qin,
• Luqiang Wang,
• Cindy Xu,
• Carmelo Carlo-Stella

Affiliations

Paolo F Caimi

1 Cleveland Clinic Taussig Cancer Center, Cleveland, United States

Weiyun Z Ai

2 Helen Diller Family Comprehensive Cancer Center, University of California, San Francisci, United States

Juan Pablo Alderuccio

3 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, United States

Kirit M Ardeshna

4 University College London Hospitals NHS Foundation Trust, London, United Kingdom

Mehdi Hamadani

5 Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, United States

Brian Hess

6 Medical University of South Carolina, Charleston, United States

Brad S Kahl

7 Washington University, St. Louis, United States

John Radford

8 NIHR Clinical Research Facility, University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom

Melhem Solh

9 Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia

Anastasios Stathis

10 Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

Pier Luigi Zinzani

11 Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy

Ying Wang

12 ADC Therapeutics America, Inc., Murray Hill, United States

Yajuan Qin

12 ADC Therapeutics America, Inc., Murray Hill, United States

Luqiang Wang

12 ADC Therapeutics America, Inc., Murray Hill, United States

Cindy Xu

12 ADC Therapeutics America, Inc., Murray Hill, United States

Carmelo Carlo-Stella

13 Department of Biomedical Sciences, Humanitas University, and Department of Oncology and Hematology, Humanitas Research Hospital - IRCCS, Milano, Italy